IgAN group:None

3 trials

Sponsors

Peking University Shenzhen Hospital, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, The First Affiliated Hospital of Zhengzhou University

Conditions

IgA nephropathyPatients with renal biopsy-proven IgA nephropathy.primary membranous nephropathy (MN) and IgA nephropathy (IgAN)

Unknown Phase

Precision Diagnosis and Treatment Research on Membranous Nephropathy and IgA Nephropathy Based on Epitranscriptomics, Structural Immunity, and Cellular Senescence Mechanisms

Active, not recruitingChiCTR2600121518

Peking University Shenzhen Hospitalprimary membranous nephropathy (MN) and IgA nephropathy (IgAN)

Start: 2026-04-01Updated: 2026-04-14

Exploring the Molecular Mechanism of ITGB2 in IgA Nephropathy

Active, not recruitingChiCTR2600126161

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical UniversityPatients with renal biopsy-proven IgA nephropathy.

Start: 2026-07-01Updated: 2026-06-08

Research on the Mechanism of Glucagon-like Peptide-1 Receptor (GLP-1R) in the Pathogenesis of IgA Nephropathy

Active, not recruitingChiCTR2600127578

The First Affiliated Hospital of Zhengzhou UniversityIgA nephropathy

Start: 2026-07-02Updated: 2026-07-13